Robert A. Zittoun, MD [clinicaltrials_resource:f804a894fb56410e4ba2ee8d9b447de4]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00002549]A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) [clinicaltrials:NCT01324063]
overall official [clinicaltrials_vocabulary:overall-official]
Robert A. Zittoun, MD [clinicaltrials_resource:f804a894fb56410e4ba2ee8d9b447de4]
Bio2RDF identifier
f804a894fb56410e4ba2ee8d9b447de4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f804a894fb56410e4ba2ee8d9b447de4
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Robert A. Zittoun, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:f804a894fb56410e4ba2ee8d9b447de4
title
Robert A. Zittoun, MD
@en
type
label
Robert A. Zittoun, MD [clinicaltrials_resource:f804a894fb56410e4ba2ee8d9b447de4]
@en